NCT00850681View on ClinicalTrials.gov

A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Actinic Keratosis
Interventions
DRUG

PEP005 (ingenol mebutate) Gel

PEP005 (ingenol mebutate) Gel, 0.01%

Trial Locations (1)

07652

TKL Research, Inc., Paramus

Sponsors

Lead Sponsor

Peplin
All Listed Sponsors
lead

Peplin

INDUSTRY

NCT00850681 - A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | Biotech Hunter | Biotech Hunter